Vonoprazan and high‐dose amoxicillin dual therapy for Helicobacter pylori first‐line eradication: A single‐arm, interventional study

BACKGROUND: To date, no interventional trial has assessed the efficacy and safety of vonoprazan and high‐dose (500 mg four times daily, 2000 mg/day) amoxicillin dual therapy in terms of Helicobacter pylori eradication. We explored whether this was an appropriate first‐line treatment. METHODS: This p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sue, Soichiro, Kondo, Masaaki, Sato, Takeshi, Oka, Hiroyuki, Sanga, Katsuyuki, Ogashiwa, Tsuyoshi, Matsubayashi, Mao, Kaneko, Hiroaki, Irie, Kuniyasu, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840190/
https://www.ncbi.nlm.nih.gov/pubmed/36660051
http://dx.doi.org/10.1002/jgh3.12852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840190/
https://www.ncbi.nlm.nih.gov/pubmed/36660051
http://dx.doi.org/10.1002/jgh3.12852

Ejemplares similares